Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Arrowhead Pharmaceuticals, Inc. (ARWR) has a Wall Street consensus price target of $78.78, based on estimates from 20 covering analysts. With the stock currently trading at $63.27, this represents a potential upside of +24.5%. The company has a market capitalization of $8.69B.
Analyst price targets range from a low of $35.00 to a high of $110.00, representing a 95% spread in expectations. The median target of $80.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ARWR trades at a trailing P/E of -5186.1x. Analysts expect EPS to grow -323.4% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ARWR stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for ARWR is $78.78, representing 24.5% upside from the current price of $63.27. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARWR has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $78.78 implies 24.5% upside from current levels.
ARWR's current price is $63.27 with a consensus target of $78.78 (24.5% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $110 for ARWR, while the most conservative target is $35. The consensus of $78.78 represents the median expectation. These targets typically reflect 12-month expectations.
ARWR is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARWR stock forecast based on 20 Wall Street analysts shows a consensus price target of $78.78, with estimates ranging from $35 (bear case) to $110 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on ARWR, with a "Buy" consensus rating and $78.78 price target (24.5% upside). 14 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARWR analyst price targets range from $35 to $110, a 95% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $78.78 consensus represents the middle ground.